GGrantIndex
← Leaderboards

Qisheng Zhang

Univ Of North Carolina Chapel Hill

$4,632,517
Attributed
$10,579,764
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,579,764 · 7

By mechanism

R01$8,957,615 · 5
R56$1,511,798 · 1
R21$110,351 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionMalignant NeoplasmsCellsProteinsLeadDesignGeneticAlzheimer&AposPharmaceutical PreparationsResponseRegulationSignal PathwayMolecularEnzymesMigrationSmall MoleculeLibrariesAnalogCell PhysiologyPlayBaseLinkMonitorInhibitor/Antagonist

Grant awards (24)

CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS$472,452
R01 · FY2025 · CA
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease$748,573
R56 · FY2024 · AG · contact PI
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes$508,118
R01 · FY2024 · CA · contact PI
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS$463,889
R01 · FY2024 · CA
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease$763,225
R56 · FY2023 · AG · contact PI
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$632,409
R01 · FY2023 · CA
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes$536,812
R01 · FY2023 · CA · contact PI
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS$497,111
R01 · FY2023 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$632,757
R01 · FY2022 · CA
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes$583,609
R01 · FY2022 · CA · contact PI
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$644,104
R01 · FY2021 · CA
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes$569,708
R01 · FY2021 · CA · contact PI
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$624,345
R01 · FY2020 · CA
Microfabricated instrumentation to measure sphingolipid signaling in human acute myeloid leukemia$586,757
R01 · FY2019 · CA
Developing Small Molecule ARFGAP Regulators to Dissect Cell Signaling$277,866
R01 · FY2015 · GM · contact PI
Developing Small Molecule ARFGAP Regulators to Dissect Cell Signaling$277,963
R01 · FY2014 · GM · contact PI
High-throughput screens to identify modulators of phospholipase C isozymes$271,358
R01 · FY2013 · GM · contact PI
Developing Small Molecule ARFGAP Regulators to Dissect Cell Signaling$268,325
R01 · FY2013 · GM · contact PI
High-throughput screens to identify modulators of phospholipase C isozymes$281,200
R01 · FY2012 · GM · contact PI
Developing Small Molecule ARFGAP Regulators to Dissect Cell Signaling$278,149
R01 · FY2012 · GM · contact PI
High-throughput screens to identify modulators of phospholipase C isozymes$281,200
R01 · FY2011 · GM · contact PI
Developing Small Molecule ARFGAP Regulators to Dissect Cell Signaling$269,483
R01 · FY2011 · GM · contact PI
High Throughput Assay Development for ARFGAP Modulators$37,000
R21 · FY2011 · NS · contact PI
High Throughput Assay Development for ARFGAP Modulators$73,351
R21 · FY2010 · NS · contact PI